Longitudinal changes in lung hyperinflation in COPD

References

• RaherisonCGirodetPOEpidemiology of COPDEur Respir Rev20091811421322120956146
   PubMedGoogle Scholar
• RennardSIDrummondMBEarly chronic obstructive pulmonary disease: definition, assessment, and preventionLancet201538599791778178825943942
   PubMed Web of Science ®Google Scholar
• FletcherCPetoRThe natural history of chronic airflow obstructionBMJ19771607716451648871704
   PubMed Web of Science ®Google Scholar
• LangePCelliBAgustiALung-function trajectories leading to chronic obstructive pulmonary diseaseN Engl J Med2015373211112226154786
   PubMed Web of Science ®Google Scholar
• VestboJEdwardsLDScanlonPDChanges in forced expiratory volume in 1 second over time in COPDN Engl J Med2011365131184119221991892
   PubMed Web of Science ®Google Scholar
• O’DonnellDELavenezianaPPhysiology and consequences of lung hyperinflation in COPDEur Respir Rev2006151006167
   Google Scholar
• O’DonnellDEGuenetteJAMaltaisFWebbKADecline of resting inspiratory capacity in COPD: the impact on breathing pattern, dyspnea, and ventilatory capacity during exerciseChest2012141375376221852298
   PubMed Web of Science ®Google Scholar
• ZamanMMahmoodSAltayehALow inspiratory capacity to total lung capacity ratio is a risk factor for chronic obstructive pulmonary disease exacerbationAm J Med Sci2010339541141420375693
   PubMed Web of Science ®Google Scholar
• CasanovaCCoteCde TorresJPInspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2005171659159715591470
   PubMed Web of Science ®Google Scholar
• ViegiGPistelliFSherrillDLMaioSBaldacciSCarrozziLDefinition, epidemiology and natural history of COPDEur Respir J2007305993101317978157
   PubMed Web of Science ®Google Scholar
• ParkTSLeeJSSeoJBKOLD Study GroupStudy design and outcomes of Korean obstructive lung disease (KOLD) cohort studyTuberc Respir Dis (Seoul)201476416917424851130
   PubMedGoogle Scholar
• VestboJHurdSSAgustiAGGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2013187434736522878278
   PubMed Web of Science ®Google Scholar
• OhYMJeongBHWooSYKOLD Study GroupAssociation of plasma adipokines with chronic obstructive pulmonary disease severity and progressionAnn Am Thorac Soc20151271005101226010877
   PubMed Web of Science ®Google Scholar
• MillerMRHankinsonJBrusascoVStandardisation of spirometryEur Respir J200526231933816055882
   PubMed Web of Science ®Google Scholar
• WangerJClausenJLCoatesAStandardisation of the measurement of lung volumesEur Respir J200526351152216135736
   PubMed Web of Science ®Google Scholar
• CrieeCPSorichterSSmithHJBody plethysmographyits principles and clinical useRespir Med2011105795997121356587
   PubMed Web of Science ®Google Scholar
• ChoiJKPaekDLeeJONormal predictive values of spirometry in Korean populationTuberc Respir Dis2005583230242
   Google Scholar
• SongEHOhYMHongSBSelection of reference equations for lung volumes and diffusing capacity in KoreaTuberc Respir Dis2006613218226
   Google Scholar
• QuanjerPHTammelingGJCotesJEPedersenOFPeslinRYernaultJCLung volumes and forced ventilatory flows. Report working party standardization of lung function tests, European Community for steel and coal. Official statement of the European Respiratory SocietyEur Respir J Suppl1993165408499054
   PubMedGoogle Scholar
• global Initiative for Chronic Obstructive Lung Disease (GOLD) [webpage on the Internet]Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease [Updated 2016] Available from: http://goldcopd.org/global-strategy-diagnosis-management-prevention-copd-2016Accessed November 14, 2016
   Google Scholar
• WedzichaJASeemungalTACOPD exacerbations: defining their cause and preventionLancet2007370958978679617765528
   PubMed Web of Science ®Google Scholar
• FitzmauriceGMRavichandranCA primer in longitudinal data analysisCirculation2008118192005201018981315
   PubMed Web of Science ®Google Scholar
• MarinJMCarrizoSJGasconMSanchezAGallegoBCelliBRInspiratory capacity, dynamic hyperinflation, breathlessness, and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200116361395139911371407
   PubMed Web of Science ®Google Scholar
• KloosterKten HackenNHHartmanJESciurbaFCKerstjensHASlebosDJDetermining the role of dynamic hyperinflation in patients with severe chronic obstructive pulmonary diseaseRespiration201590430631326352833
   PubMed Web of Science ®Google Scholar
• SatakeMShioyaTUemuraSDynamic hyperinflation and dyspnea during the 6-minute walk test in stable chronic obstructive pulmonary disease patientsInt J Chron Obstruct Pulmon Dis20151015315825632228
   PubMed Web of Science ®Google Scholar
• ThomasMDecramerMO’DonnellDENo room to breathe: the importance of lung hyperinflation in COPDPrim Care Respir J201322110111123429861
   PubMedGoogle Scholar
• RamonMAFerrerJGimeno-SantosEPAC-COPD Study GroupInspiratory capacity-to-total lung capacity ratio and dyspnoea predict exercise capacity decline in COPDRespirology201621347648226714424
   PubMed Web of Science ®Google Scholar
• FrenchABalfeDMirochaJMFalkJAMosenifarZThe inspiratory capacity/total lung capacity ratio as a predictor of survival in an emphysematous phenotype of chronic obstructive pulmonary diseaseInt J Chron Obstruct Pulmon Dis2015101305131226203237
   PubMed Web of Science ®Google Scholar
• DeesomchokAWebbKAForkertLLung hyperinflation and its reversibility in patients with airway obstruction of varying severityCOPD20107642843721166631
   PubMedGoogle Scholar
• CorbinRPLovelandMMartinRRMacklemPTA four-year follow-up study of lung mechanics in smokersAm Rev Respir Dis19791202293304475151
   PubMed Web of Science ®Google Scholar
• CortopassiFCelliBDivoMPinto-PlataVLongitudinal changes in handgrip strength, hyperinflation, and 6-minute walk distance in patients with COPD and a control groupChest2015148498699425996450
   PubMed Web of Science ®Google Scholar
• CelliBRDecramerMLystigTKestenSTashkinDPLongitudinal inspiratory capacity changes in chronic obstructive pulmonary diseaseRespir Res2012136622866681
   PubMed Web of Science ®Google Scholar
• Orozco-LeviMStructure and function of the respiratory muscles in patients with COPD: impairment or adaptation?Eur Respir J Suppl20034641s51s14621106
   PubMedGoogle Scholar
• VestboJAndersonJABrookRDSUMMIT InvestigatorsFluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised controlled trialLancet2016387100301817182627203508
   PubMed Web of Science ®Google Scholar
• TashkinDPCelliBSennSA 4-year trial of tiotropium in chronic obstructive pulmonary diseaseN Engl J Med2008359151543155418836213
   PubMed Web of Science ®Google Scholar
• CelliBRThomasNEAndersonJAEffect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH studyAm J Respir Crit Care Med2008178433233818511702
   PubMed Web of Science ®Google Scholar
• HartmanJETen HackenNHKloosterKBoezenHMde GreefMHSlebosDJThe minimal important difference for residual volume in patients with severe emphysemaEur Respir J20124051137114122441742
   PubMed Web of Science ®Google Scholar
• KannerREAnthonisenNRConnettJELower respiratory illnesses promote FEV1 decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health studyAm J Respir Crit Care Med2001164335836411500333
   PubMed Web of Science ®Google Scholar
• DonaldsonGCSeemungalTABhowmikAWedzichaJARelationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary diseaseThorax2002571084785212324669
   PubMed Web of Science ®Google Scholar
• HalpinDMDecramerMCelliBKestenSLiuDTashkinDPExacerbation frequency and course of COPDInt J Chron Obstruct Pulmon Dis2012765366123055714
   PubMed Web of Science ®Google Scholar
• WedzichaJABrillSEAllinsonJPDonaldsonGCMechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary diseaseBMC Med20131118123945277
   PubMed Web of Science ®Google Scholar